SCHEMBL23309568

SCHEMBL23309568

O=C(Nc1cccc(C(F)(F)F)c1)c1cc(F)nc(F)c1F

nearest known ligand 0.59

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 2/20 0.59
▸ PTGS1 P23219 1/20 0.57
▸ MAPT P10636 1/20 0.57
▸ RXFP1 Q9HBX9 11/20 0.56
▸ KMT2A Q03164 2/20 0.55
▸ GAA P10253 1/20 0.55
▸ AHR P35869 1/20 0.55
▸ HSD17B10 Q99714 1/20 0.55
▸ SLC2A1 P11166 1/20 0.54
▸ P2RX4 Q99571 1/20 0.54
▸ P2RX7 Q99572 1/20 0.54
▸ TMPRSS4 Q9NRS4 1/20 0.54
▸ SMN1; SMN2 Q16637 1/20 0.54
▸ MAOB P27338 1/20 0.54
▸ MEN1 O00255 1/20 0.53
▸ OPRK1 P41145 1/20 0.53
▸ HTT P42858 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309490 0.82 GAA (0.51) KMT2AGAAHSD17B10SMN1; SMN2MAOB
SCHEMBL23309548 0.82 FADS1 (0.55) P2RX1MAPTKMT2AGAAAHR
SCHEMBL23309536 0.82 MEN1 (0.55) RXFP1KMT2AGAAHSD17B10SMN1; SMN2
SCHEMBL23309615 0.81 P2RX1 (0.58) P2RX1MAPTGAAHTT
SCHEMBL23309685 0.81 MAPT (0.71) P2RX1PTGS1MAPTRXFP1KMT2A
SCHEMBL23309730 0.80 KMT2A (0.47) P2RX1MAPTKMT2AGAASMN1; SMN2
SCHEMBL23309512 0.79 HTT (0.57) P2RX1MAPTRXFP1KMT2AGAA
SCHEMBL23309513 0.79 RAB9A (0.63) RXFP1KMT2AGAASMN1; SMN2MEN1
SCHEMBL23309703 0.77 RAB9A (0.51) KMT2ASMN1; SMN2MAOBMEN1HTT
SCHEMBL31171402 0.77 P2RX1 (0.57) P2RX1PTGS1MAPTRXFP1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL P2RX1 2860/4885PTGS1 1417/4885MAPT 1126/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback